SCHEMBL18156799

SCHEMBL18156799

Brc1cccc2c1-c1ccccc1C21c2ccccc2-c2cc3c(cc21)Cc1ccccc1-3

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KDM4E B2RXH2 2/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40
ALDH1A1 P00352 2/20 0.40
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
HPGD P15428 1/20 0.40
PGR P06401 2/20 0.36
SRD5A2 P31213 1/20 0.33
HTR2C P28335 2/20 0.32
HTR2B P41595 2/20 0.32
DRD2 P14416 1/20 0.32
ADRA1D P25100 1/20 0.32
HTR2A P28223 1/20 0.32
HTR7 P34969 1/20 0.32
ADRA1A P35348 1/20 0.32
ADRA1B P35368 1/20 0.32
CYP1A2 P05177 6/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18156797 0.95 PDK2 (0.40) PDK2SMN1; SMN2KDM4ELMNAMAPT
SCHEMBL18156793 0.82 PDK2 (0.43) PDK2SMN1; SMN2KDM4ELMNAMAPT
SCHEMBL10053123 0.81 PDK2 (0.56) PDK2SMN1; SMN2KDM4ELMNAMAPT
SCHEMBL29484645 0.81 PDK2 (0.56) PDK2SMN1; SMN2KDM4ELMNAMAPT
SCHEMBL18156810 0.80 TDP1 (0.41) PDK2SMN1; SMN2KDM4ELMNAMAPT
SCHEMBL18156789 0.80 PDK2 (0.41) PDK2SMN1; SMN2KDM4ELMNAMAPT
SCHEMBL18156791 0.80 PDK2 (0.41) PDK2SMN1; SMN2KDM4ELMNAMAPT
SCHEMBL16810667 0.79 PDK2 (0.54) PDK2SMN1; SMN2KDM4ELMNAMAPT
SCHEMBL17816712 0.79 PDK2 (0.54) PDK2SMN1; SMN2KDM4ELMNAMAPT
SCHEMBL19773095 0.79 PDK2 (0.54) PDK2SMN1; SMN2KDM4ELMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2023-04-27 US disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 PDK2 264/4885SMN1; SMN2 3900/4885KDM4E 4246/4885
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 PDK2 264/4885SMN1; SMN2 3900/4885KDM4E 4246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.